Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
Benjamin Diamond(Memorial Sloan Kettering Cancer Center), Neha Korde(Memorial Sloan Kettering Cancer Center), Alexander M. Lesokhin(Memorial Sloan Kettering Cancer Center), Eric L. Smith(Dana-Farber Cancer Institute), Urvi A. Shah(Memorial Sloan Kettering Cancer Center), Sham Mailankody(Memorial Sloan Kettering Cancer Center), Malin Hultcrantz(Memorial Sloan Kettering Cancer Center), Hani Hassoun(Memorial Sloan Kettering Cancer Center), Sydney X. Lu(Memorial Sloan Kettering Cancer Center), Carlyn Tan(Memorial Sloan Kettering Cancer Center), Even H Rustad(Memorial Sloan Kettering Cancer Center), Francesco Maura(Sylvester Comprehensive Cancer Center), Kylee Maclachlan(Memorial Sloan Kettering Cancer Center), Tim Peterson(Memorial Sloan Kettering Cancer Center), Andriy Derkach(Memorial Sloan Kettering Cancer Center), Sean M. Devlin(Memorial Sloan Kettering Cancer Center), Heather Landau(Memorial Sloan Kettering Cancer Center), Michael Scordo(Memorial Sloan Kettering Cancer Center), David J. Chung(Memorial Sloan Kettering Cancer Center), Gunjan L. Shah(Memorial Sloan Kettering Cancer Center), Oscar Lahoud(Memorial Sloan Kettering Cancer Center), Katie Thoren(Memorial Sloan Kettering Cancer Center), Kazunori Murata(Memorial Sloan Kettering Cancer Center), Lakshmi V. Ramanathan(Memorial Sloan Kettering Cancer Center), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Caleb Ho(Memorial Sloan Kettering Cancer Center), Mikhail Roshal(Memorial Sloan Kettering Cancer Center), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Sergio Giralt(Memorial Sloan Kettering Cancer Center), Ola Landgren(Sylvester Comprehensive Cancer Center)
Cited by 94
Abstract
Related Papers
No related papers found
Powered by citation graph analysis